Human cancers frequently harbour mutations in DNA repair genes, rendering the use of DNA damaging agents as an effective therapeutic intervention. As therapy-resistant cells often arise, it is important to better understand the molecular pathways that drive resistance in order to facilitate the eventual targeting of such processes. We employ repair-defective diploid yeast as a model to demonstrate that, in response to genotoxic challenges, nearly all cells eventually undergo checkpoint adaptation, resulting in the generation of aneuploid cells with whole chromosome losses that have acquired resistance to the initial genotoxic challenge. We demonstrate that adaptation inhibition, either pharmacologically, or genetically, drastically reduces the occurrence of resistant cells. Additionally, the aneuploid phenotypes of the resistant cells can be specifically targeted to induce cytotoxicity. We provide evidence that TORC1 inhibition with rapamycin, in combination with DNA damaging agents, can prevent both checkpoint adaptation and the continued growth of aneuploid resistant cells.
Introduction
To preserve genome stability, eukaryotic cells have developed elaborate, and highly conserved, mechanisms to deal with DNA damage. In response to double-strand breaks (DSBs), a signalling cascade termed the DNA damage checkpoint (DDC) is activated to arrest the cell cycle before sister chromatid segregation occurs (reviewed in 1 ). The DDC is essential to prevent the propagation of cells with damaged chromosomes, which leads to genome instability, as well as providing time for the repair of the damaged DNA. The main steps in DDC activation in Saccharomyces cerevisiae comprise nucleolytic processing by the MRX complex and other nucleases [2] [3] [4] to allow recognition of the damage site via Mec1/Ddc2 5 . Subsequently, Mec1
activates the checkpoint effector kinases Rad53 and Chk1 utilizing the checkpoint mediator Rad9 [6] [7] [8] . To achieve a cell cycle arrest, Rad53 targets securin/Pds1 to prevent sister chromatid separation 9 and inhibits the pro-mitotic kinase Cdc5 10-13 , the yeast homologue of human Pololike kinase 1 (PLK1) 14 . In addition, Rad53 triggers a transcriptional response to DNA damage [15] [16] [17] .
Repair of DSBs is facilitated by two major pathways, namely homologous recombination (HR)
and non-homologous end joining (NHEJ). The choice between these pathways is influenced by the cell cycle stage and hence the ability to resect the broken DNA ends, as well as the ploidy state 18 . Diploid yeast cells actively suppress NHEJ throughout the cell cycle on the transcriptional level, rendering them dependent on HR to repair DSBs [19] [20] [21] . To engage in HR, DSB ends are resected and rapidly bound by the ssDNA binding protein RPA 3, 22 . Rad52, which is essential for HR-mediated repair in yeast, then promotes the replacement of RPA with the recombinase Rad51 23, 24 . Rad52-mediated loading of Rad51 is assisted by Rad55 and Rad57 25 .
The Rad51-ssDNA nucleoprotein filament then scans the genome for intact homologous template sequences to drive the error-free repair reaction 26, 27, 28 . Following successful DNA repair, the checkpoint is eventually extinguished and cells are able to continually divide, a process referred to as checkpoint recovery 29, 30 .
In certain scenarios, DNA damage can be considered irreparable as dictated by the nature of damage, i.e. where the damage occurs (e.g. telomeres), or the genetic context of the cell (e.g.
loss of RAD52 in diploid yeast). In response to persistent damage, DDC signalling can however still be terminated, in a process termed checkpoint adaptation 31, 32 . Checkpoint adaptation is considered to be a last effort to maintain cell viability and avoid cell death by attempting to either tolerate the DNA damage load, or repair by alternative means 33 . In response to genotoxic stress and dysfunctional telomeres, checkpoint adaptation precedes genomic instability 34, 35 and facilitates the use of mutagenic repair pathways including break-induced replication (BIR) 34 .
Importantly, checkpoint adaptation has been documented in both uni-and multicellular systems including budding yeast, Xenopus egg extracts, plant and cancer cells 31, 32, [36] [37] [38] [39] [40] . One striking similarity in the process of checkpoint adaptation across all organisms is the critical contribution of PLK1 41, 42 and its homologues such as budding yeast Cdc5 31 . An allele of CDC5 (cdc5-ad), which harbours a single point mutation (L251W), is specifically defective in checkpoint adaptation 31 . The nutritional status of a cell can also impact the decision to undergo checkpoint adaptation 43 . More specifically, inhibition of the highly conserved TOR complex 1 (TORC1) by rapamycin treatment was shown to prevent checkpoint adaptation in response to chronic dysfunctional telomeres 43 . TORC1 not only promotes checkpoint adaptation in the presence of unrepaired DNA damage 43 but also enables chromosome mis-segregation by activating the Glc7/PP1 phosphatase, an opponent of the spindle assembly checkpoint (SAC)
protein, Ipl1 44 .
It has long been recognized that yeast cells lacking Rad52 experience extensive chromosome loss after irradiation 45 , however direct links to checkpoint adaptation have not been drawn.
Extensive studies on yeast and mammalian cells with abnormal chromosome numbers (aneuploid cells) have identified a common aneuploidy-associated phenotype characterized by increased levels of proteotoxic stress resulting from imbalanced protein expression 46-50 , delayed cell cycle progression [51] [52] [53] , metabolic stress 47, 48 , non-genetic heterogeneity between clones 51 as well as increased and persistent DNA damage 54, 55 . Many of these phenotypes that exist in aneuploids are susceptible to being targeted by pharmacological agents 48 .
In this study, we have used repair-defective diploid yeast as a model to better understand the consequences of checkpoint adaptation following a challenge with clinically relevant genotoxic agents. We observe that the re-growth of repair-defective cells almost exclusively depends on checkpoint adaptation. All of the adapted cells that we characterized had undergone chromosome loss, rendering them aneuploid, and had acquired resistance to further DNA damaging agents. By combining genotoxins with inhibitors of checkpoint adaptation or with aneuploidy-selective agents, we were able to synergistically enhance the cytotoxicity of repairdefective cells, while repair-proficient cells remained unscathed. These results suggest that combination therapies targeting checkpoint adaptation and aneuploidy-associated phenotypes together with conventional DNA damaging chemotherapeutics, may be considered in human cancers with mutations in DNA repair genes.
Results

Checkpoint adaptation drives resistance to genotoxic challenge
To better characterise the cellular consequences of checkpoint adaptation, we established a model where adapted cells could be recovered in a reproducible manner for further analysis. To this end, a previous study has demonstrated that diploid repair-deficient rad52 mutants readily undergo checkpoint adaptation following exposure to X-rays 34 . We performed similar experiments by treating repair-defective homozygous diploids, deleted for the RAD52 gene, with camptothecin (CPT), which induces double-strand breaks (DSBs) by trapping Top1
cleavage complexes (Top1cc) on the DNA 56 . As expected, in the presence of CPT, rad52 cells were unable to form colonies on agar plates after 2 days, unlike wild type cells or unchallenged rad52 cells (Fig. 1a and data not shown). Following 5 days of incubation, small colonies began to form, which were clearly visible after 8 days (Fig. 1a) . Despite their growth, the colonies contained a large fraction of metabolically inactive cells as indicated by the accumulation of the vital dye Phloxine B (pink colouring) 57 . Colony formation was not a result of decreased CPT activity over time, as CPT-containing plates incubated at 30°C for 7 days were as effective in killing rad52 cells as freshly prepared plates ( Supplementary Fig. 1a ). Quantification of cell survival normalized to "no drug" control plates revealed that approximately 85 % of the plated rad52 mutants were able to eventually form colonies following prolonged incubation on CPT solid agar plates (Fig. 1b) . To demonstrate that checkpoint adaptation was responsible for the growth of repair-defective rad52 cells on CPT, we introduced the adaptation-defective cdc5-ad allele 31 . Survival of adaptation-deficient rad52 cdc5-ad mutants was strongly reduced (to approximately 30 %, Fig. 1a, b) , suggesting that checkpoint adaptation is required for the delayed colony formation. In cells that were repair competent, the presence of the cdc5-ad allele had no effect on viability following CPT challenge (Fig. 1a, b) . Similar results were obtained when X-rays were used as a source of DNA damage (Fig. 1c, Supplementary Fig. 1b ) as previously described 34 . In response to the radiomimetic drug bleomycin, adaptation-deficient rad52 cdc5-ad cells were also significantly sensitized to the drug treatment compared to rad52 CDC5 mutants ( Supplementary Fig. 1c ). Therefore, Cdc5-mediated checkpoint adaptation promotes the delayed survival and growth of repair-defective cells following genotoxic stress.
To confirm that the cdc5-ad associated decreased viability was a result of checkpoint maintenance, we employed the checkpoint-defective rad53-11 allele 8 to see if it would abolish the enhanced sensitivity phenotype. Indeed, preventing adaptation in rad52 cdc5-ad mutants was only able to decrease viability following CPT or X-ray treatment in a checkpoint-competent RAD53 background but not in rad53-11 cells (Fig. 1d, e) .
To investigate if adapted rad52 mutants that were able to eventually survive genotoxic stress had acquired drug resistance, we exposed the adapted cells to a second genotoxic challenge. As shown in Fig. 1f , adapted repair-defective mutants derived from CPT-containing plates (rad52 (CPT)) displayed a significant growth advantage as compared to rad52 cells that had not been previously exposed to CPT (rad52 (YPD)). The few rad52 cdc5-ad cells that had adapted also acquired drug resistance. Similar drug resistance was observed in adapted cells that had been exposed to X-rays, however, these cells remained sensitive to CPT ( Supplementary Fig. 1d ).
Together, these results suggest that the development of genotoxin resistance in repair-defective cells is promoted by checkpoint adaptation.
Rapamycin can prevent checkpoint adaptation in repair defective cells
We have previously demonstrated that treating cells with the TORC1 inhibitor rapamycin, prevents checkpoint adaptation in response to DNA damage arising from chronic dysfunctional telomeres 43 . To determine whether rapamycin was also able to prevent checkpoint adaptation in diploid rad52 cells after genotoxic treatment, we analysed cell division in a microcolony assay. G1 or S phase cells were micromanipulated onto agar plates containing the indicated drugs and checkpoint adaptation was scored as the appearance of microcolonies consisting of more than 2 or 4 cell bodies (Fig. 2a ) 31, 58 . The presence of rapamycin significantly reduced the frequency of checkpoint adaptation in response to both X-ray ( Fig. 2b ) and CPT treatment ( To test the effects on cell survival, we concomitantly exposed rad52 cells to rapamycin and CPT, which resulted in approximately 25 % cell survival of rad52 mutants compared to approximately 94 % survival after CPT treatment alone (Fig. 2d) . In contrast to the cdc5-ad allele (Fig. 1d, e) , the decrease in cell survival due to rapamycin was not reversed when the checkpoint was compromised by introducing the rad53-11 allele (Fig. 2d) 
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. Moreover, the presence of rapamycin led to an additive effect in decreasing cell survival of adaptationdeficient rad52 cdc5-ad mutants (Fig. 2e) . Similar results were obtained when using X-rays as a source of DNA damage instead of CPT ( Supplementary Fig. 2a, b) .
In summary, rapamycin, like the cdc5-ad allele, is able to prevent checkpoint adaptation in repair-defective cells exposed to genotoxic agents. Furthermore, the strong loss of viability when combining either rapamycin (Fig. 2d , e, Supplementary Fig. 2a, b ) or cdc5-ad (Fig. 1b, c) with genotoxic agents is specific to repair-defective cells, as repair-proficient cells remain fully viable. Unlike the cdc5-ad allele, rapamycin is also able to impart toxicity in a checkpointindependent manner (Fig. 2d, Supplementary Fig. 2a ), which can account for the additive cytotoxicity when rad52 cdc5-ad cells are exposed to rapamycin in the presence of genotoxins (Fig. 2e, Supplementary Fig. 2b ).
Adapted repair-defective cells become aneuploid
In the absence of RAD52, chromosome loss is frequently observed and this is exacerbated upon X-ray treatment 45 . Consistently, DNA content analysis of adapted rad52 mutants after genotoxic treatment revealed a high degree of chromosome loss resulting in aneuploid cells ranging from near diploid to near haploid DNA contents (Fig. 3a) . By employing a wholegenome sequencing approach on the strains depicted in Fig. 3a , we were able to conclude that the aneuploidy was a result of whole chromosome loss events (Fig. 3b) . Accordingly, pulsedfield gel electrophoresis indicated that in our conditions, gross chromosomal rearrangements were not occurring in the adapted cells ( Supplementary Fig. 3a) . Following CPT treatment of rad52 cells we observed the loss of one copy of nearly all chromosomes, with the exception of chromosome III (Fig. 3b ). This DNA content was stably maintained over several rounds of passaging (not shown). In contrast, X-ray irradiation produced rad52 mutants with a variety of karyotypic changes ranging from extensive chromosome loss to individual loss events (Fig. 3a, b, lower 3 karyotypes). Although representative DNA content analyses for only 5 adapted strains are depicted in Figure 3a , this was highly reproducible in the over 50 adapted clones that were tested for DNA content (data not shown). Preventing adaptation in a cdc5-ad genetic background largely impaired the regrowth of repair-defective cells following genotoxic stress (Fig. 1b, c) , however, it was not completely abolished, and the rare rad52 cdc5-ad mutants that were able to form colonies also underwent extensive chromosome loss ( Supplementary Fig.   3b ). To rule out that the reduction in chromosome numbers may have occurred through the induction of meiosis, we deleted the SPO11 gene in rad52 mutants 59 , and exposed them to CPT. In the meiosis-defective cells, we observed that the number of adapted cells was not altered ( Supplementary Fig. 3c ), and moreover, the aneuploid karyotype remained prevalent ( Supplementary Fig. 3d ).
The phenotypes associated with aneuploidy in yeast have largely been described based on the experimental creation of disomic strains 47, 49, 60, 61 . We tested whether checkpoint adapted aneuploids display similar phenotypes. Due to imbalances in protein complexes disomic strains are defective in maintaining proteostasis, which can be visualized by the inability to resolve Hsp104-GFP positive protein aggregates following heat challenge 49 . Indeed, checkpoint adapted aneuploids (derived from X-ray irradiation) were impaired in resolving Hsp104-GFP foci following 3 hours at 37 °C, when compared to naiive rad52 mutants and wild type cells (Fig. 3c, d ). Consistently, many of these X-ray adapted aneuploids were severely impaired for growth at 37 °C, which correlated with their ability to resolve Hsp104-GFP foci (Fig. 3e ). The cells that adapted from CPT treatment, which were almost exclusively disomic for chromosome III, but otherwise haploid, did not show defects in Hsp104-GFP foci resolution, nor were they impaired for growth at 37 °C ( Supplementary Fig. 3e , f, g).
In summary, following checkpoint adaptation, the resistant cells that arise undergo extensive chromosome loss and a sub-set of them display aneuploidy-associated phenotypes similar to laboratory-derived disomes.
Checkpoint adapted aneuploids can be targeted pharmacologically
The fact that aneuploid cells display proteotoxic stress opens an opportunity to target proteostasis regulators in order to induce cytotoxicity [46] [47] [48] [49] . We treated adapted aneuploids with low doses of the proteasome inhibitor, MG132, and observed a striking effect on population doubling time as compared to naiive wild type or rad52 cells (Fig. 4a) . Consistent with the fact that adaptation to CPT did not result in defective Hsp104-GFP foci resolution following heat stress ( Supplementary Fig. 3e , f), they did not show enhanced sensitivity to MG132
( Supplementary Fig. 4a ). Apart from sensitivity to proteostatic perturbations, aneuploid cells have also been reported to have altered energy demands, hence rendering them sensitive to TORC1 inhibitors, such as rapamycin 47, 48 . Indeed, adaptation following X-ray treatment rendered cells hyper-sensitive to low doses of rapamycin (Fig. 4b ). Adaptation to CPT did not result in rapamycin resistance ( Supplementary Fig. 4b ). It has been previously reported that aneuploid cells display characteristic but extremely heterogeneous response patterns after stress 51 , which can be clearly observed in the reactions to MG132 (Fig. 4a ) and rapamycin ( Fig. 4b ).
We directly compared the deviations between growth rates in unchallenged conditions and could confirm that there is significant difference between adapted cells and naiive rad52 mutants ( Fig. 4c ).
To further understand the nature of the rapamycin sensitivity, we monitored TORC1 activity in checkpoint adapted cells by following the levels of phosphorylated Sch9 (p-Sch9), a direct target of TORC1 62 . Whereas TORC1 activity was already reduced in naiive rad52 cells compared to wild type, the checkpoint adapted aneuploids had even further reduced levels of p-Sch9 (Fig. 4d) . Moreover, using the GFP-Atg8 reporter 48 , we observed increased levels of autophagy in X-ray adapted cells ( In summary, these data demonstrate that although adapted cells acquire genotoxin resistance, their aneuploid status renders them sensitive to agents that target proteostasis and energy regulation pathways.
CPT adapted cells rely on MRX-mediated DNA damage repair
We next set out to address why checkpoint adapted cells become resistant to further genotoxic challenges. In order to test if adapted rad52 mutants were still checkpoint-proficient following an adaptation event, we challenged mutants derived from either CPT-containing plates or irradiated with 45 Gy for a second time with CPT ( Fig. 5a ) and 45 Gy ( Supplementary Fig. 5a ),
respectively. To monitor DNA damage checkpoint activation, we followed the phosphorylation-dependent mobility shift of Rad53 63 as well as the induction of ribonucleotide reductase 3 (Rnr3) expression 64 . We observed that all adapted rad52 mutants had a basal activation of the DNA damage checkpoint, however they were still proficient in checkpoint activation following exposure to the respective DNA damaging agent, ruling out the notion that a faulty checkpoint may allow for the resistance phenotype.
We therefore tested whether an alternative repair mechanism would allow the survival of postadaptation rad52 mutants 65, 66 . In addition to homologous recombination, non-homologous end joining (NHEJ) constitutes the second major DSB repair pathway. However, in diploid yeast strains, as used in our experiments, NHEJ is actively suppressed by the transcriptional repression of critical NHEJ factors [19] [20] [21] . Nevertheless, since the adapted cells lose chromosomes and resemble a more "haploid-like" karyotype, we sought to address if the survival of rad52 mutants after genotoxic stress was facilitated by the aberrant use of NHEJ. To test this, we exposed rad52 mutants lacking DNA ligase IV (Dnl4), a crucial NHEJ factor, to genotoxic stress. The absence of DNL4 did not compromise cell survival of rad52 mutants in the presence of CPT (Fig. 5b) or after X-ray irradiation ( Supplementary Fig. 5b ). We further investigated the involvement of other repair pathways and found that the deletion of either RAD59, RAD51, RAD55, RAD1 or POL4 did not hinder the formation of adapted colonies following either CPT or X-ray exposure in a rad52 background ( Supplementary Fig. 5c-g ). Strikingly, the deletion of MRE11, prevented the growth of adapted cells in the presence of CPT (Fig. 5c, d ), but not following X-ray exposure ( Supplementary Fig. 5h ). Another MRX (Mre11-Rad50-Xrs2) component, Rad50, also contributed to the re-growth of CPT adapted cells ( Supplementary Fig.   5i , j).
Since Mre11 does not contribute to adaptation per se 4 , we considered that it may become essential for repair post-adaptation. To address this, we created an auxin-inducible degron (AID) version of Mre11 (Fig. 5e) . We allowed rad52 cells to adapt and form colonies in the presence of Mre11 and then assessed their sensitivity to CPT following auxin (IAA)-induced removal of Mre11. Indeed, we observed that adapted rad52 cells acquire resistance to CPT in the presence of Mre11, but become sensitive following the subsequent removal of Mre11
(addition of IAA) (Fig. 5f ). The sensitivity exceeds that of losing Mre11 in the presence of Rad52.
Together, these data suggest that the MRX complex contributes to the resistance phenotype of adapted rad52 cells in response to chronic CPT exposure.
Discussion
Due to the fact that many human cancers harbour mutations in DNA repair genes, the use of genotoxic agents is frequently effective in the initial reduction of tumor size. Unfortunately, these treatments become ineffective as chemotherapy resistance develops. Therefore, it is essential to characterize the molecular events that occur when repair-defective cells are treated with genotoxins so that the pathways which lead to resistance can also be targeted in a combinatorial manner. We have employed repair-defective diploid yeast (rad52/rad52), as a model to gain insights into these processes. Here, we demonstrate that in response to ionising radiation, as previously shown 34 , and CPT treatment, checkpoint adaptation contributes to the eventual re-growth of cells. Importantly, the adapted cells that re-grow are resistant to further genotoxic challenges and undergo extensive whole chromosome losses (Figure 3 ), translocations and break-induced replication 34 . By preventing checkpoint adaptation through expression of cdc5-ad, or rapamycin treatment, the number of resistant colonies that form is drastically reduced. Moreover, rapamycin can also cause cytotoxicity in a post-adaptive manner, due to the aneuploid nature of the cells 47, 48 . Taken together, we describe the sequence of events that occur when repair-defective cells acquire drug resistance, and demonstrate options for targeting them either genetically or pharmacologically. in the presence of rapamycin 67, 68 , although the role of checkpoint adaptation was not assessed in these studies. Furthermore, inhibition of PLK1 also leads to PARPi hypersensitization in BRCA1 -/-cells 69 .
Aneuploid cells experience proteotoxic stress due to imbalances in multi-subunit protein complexes, rendering them particularly sensitive to perturbations in protein quality control pathways [46] [47] [48] [49] [50] . Consistently we found that aneuploids resulting from adaptation were hypersensitive to the proteasome inhibitor, MG132. Adaptation-derived aneuploid cells were also sensitive to rapamycin (Figure 4) , supposedly due to their altered energy demands owing to proteotoxic stress 47, 53, 70 . Therefore, rapamycin is particularly interesting as it can prevent checkpoint adaptation 43 , but can also target aneuploids following adaptation ( Figure 6 ). This explains the observations that in repair-defective cells exposed to genotoxins, rapamycin is additive with the adaptation-defective cdc5-ad allele (Fig. 2e) and is still prevents regrowth of checkpoint-defective cells (Fig. 2d) . In contrast, the enhanced cytotoxicity of the cdc5-ad allele in rad52 cells depends on the presence of the checkpoint, indicating that its action is solely through the DDC (Fig. 1d, e) . Previous studies suggest that rapamycin inhibits Cdc5 function, which is likely how it prevents checkpoint adaptation 43, 71 . How rapamycin specifically targets aneuploids remains enigmatic, although we have observed that TORC1 signalling is reduced in adapted cells as compared to naiive rad52 and wild type cells (Fig. 4d, e) .
Interestingly, CPT caused more extensive chromosome loss that X-ray treatment (Fig. 3b) whereby the CPT adapted cells were nearly exclusively disomic, having only one extra chromosome. X-ray adapted cells were very heterogeneous and were more "extreme" in the extent of their chromosome imbalances. This was also reflected in the extent of the sensitivity of the cells to proteotoxic stress and rapamycin (compare Fig. 3 and 4 with Supplementary Fig.   3 telomere shortening also frequently adapt, which leads to subsequent genome instability 35 . It is tempting to speculate that by preventing adaptation, it may also lead to the elimination of senescent cell. In agreement, we have previously demonstrated that the longevity extension properties of rapamycin are partially dependent on the DNA damage checkpoint 43 .
Taken together, we have used a yeast model to demonstrate the path taken by repair-defective cells in order to achieve drug resistance and by characterizing these cells, have elucidated ways to prevent their occurrence.
Methods
Spotting assay
Overnight cultures grown in YPD at 30 °C were spotted in tenfold serial dilutions starting with OD600nm 0.5 in the first dilution onto the indicated agar plates. Images were taken after 3 to 4 days (unless indicated otherwise) using the ChemiDoc™ Touch Imaging System (Bio-Rad).
Agar plates contained the vital dye Phloxine B at a final concentration of 8 µg/mL.
Western Blotting
Protein extraction was performed as described 43 . Briefly, cell pellets corresponding to 2 
DNA content analysis using flow cytometry
Cell pellets equivalent to 0.18 OD600nm units were harvested by centrifugation, washed once in 1 mL water to remove medium and resuspended in 300 µL water. After fixation in 70 % ethanol, cells were centrifuged and washed in 1 mL water. After centrifugation, pellets were resuspended in 500 µL 50 mM Tris-HCl pH 7.5 containing 10 mg/mL RNase A and incubated at 37 °C for 3 h or overnight. After centrifugation, pellets were resuspended in 500 µL 50 mM
Tris-HCl pH 7.5 containing 1 mg/mL Proteinase K and incubated at 50 °C for 45 min. Finally, cells were resuspended in 500 µL 50 mM Tris-HCl pH 7.5. Sonification was performed for 10 sec at level 1 using "constant" mode with a 3 mm sonification tip (Branson) or in a Bioruptor Pico (Diagenode) for 2 cycles 30 sec each. Subsequently, 500 µL 50 mM Tris-HCl pH 7.5 containing 2 µM Sytox Green were added (final concentration 1 µM), cells were transferred to
FACS tubes (Falcon) and analysed on a FACSVerse flow cytometer (BD) using FACS Suite software (BD).
Creation of homozygous diploids
Isogenic haploids of mating type a or α, respectively, were transformed using a standard protocol with different plasmids conferring either antibiotic resistance or bearing auxotrophic markers (plasmids are listed in Supplementary Table 3 ). After mating under standard conditions, homozygous diploid selection was performed using the plasmid-borne markers.
For plasmid-free diploid selection, isogenic haploids were mated in liquid YPD medium at 30 °C for 5 h and diploids were picked based on morphology using a MSM 400 dissection microscope (Singer Instruments) followed by confirmation based on DNA content.
Genotoxic treatment procedures
For X-ray treatment, cells were irradiated with the indicated doses after plating on YPD agar plates using a 0.5 mm aluminium filter to remove low-energy X-rays. The dose rate was kept constant and was set to approximately 0.9 Gy/min at 130 kV and 5 mA. For further analysis, X-ray resistant colonies were picked directly from the irradiated plates.
For camptothecin treatment, cells were plated onto YPD agar plates containing the indicated drug concentration. After the formation of resistant colonies, they were patched onto YPD agar plates and afterwards used for further analysis.
Plating assay and statistical analysis of cell survival
Cells were taken from 5 mL overnight cultures in YPD at 30 °C and cell numbers per mL were assessed by counting in a Neubauer counting chamber. 300 cells were plated in 2 technical
replicates and incubated at 30 °C for the indicated times. Plate images were taken with an Epson Perfection V700 scanner. Colonies were counted manually taking all colonies visible by eye into account and the average of the two technical replicates was used for further quantification.
Colony numbers on plates with genotoxic treatment were normalized to number of colonies formed on control YPD plates and expressed as % survival. If not indicated otherwise, every quantification represents three biological replicates. Statistical analysis was performed using one-way ANOVA with Tukey's post-hoc test after confirming normal data distribution (Shapiro-Wilk test) and testing the heterogeneity of variances (Brown-Forsythe test) as built-in analyses in the Prism 7.02 software package (GraphPad). In the case of plating assays where genotype and treatment represented two different factors, normal data distribution and variance heterogeneity were tested as before. Subsequently, a two-way ANOVA was used to confirm statistically significant interaction between the two factors followed by Tukey's post-hoc test to report statistically significant differences between data sub-groups.
Microcolony assay
Cells were grown to saturation overnight in YPD medium at 30 °C. For X-rays as a damaging agent, cells were diluted 1:10 in fresh YPD and transferred to a petri dish followed by irradiation with 45 Gy. Afterwards, unbudded or small budded cells were manipulated onto YPD agar plates containing either 10 nM rapamycin (in DMSO) or DMSO. Based on a similar experiment performed in 31 , microcolony formation was assessed by quantifying cell bodies, i.e. a cell arrest in G2/M evident as a dumbbell shape was counted as 2 cell bodies. Microcolonies that contained only one cell body at the 4 h time point were excluded from further analysis. After 24 h, cell bodies present in every microcolony were counted. Cells were counted as adapted if the microcolony contained more than 2 cell bodies. Normal data distribution was tested using the Shapiro-Wilk test. Since data were not normally distributed, a Kruskal-Wallis test followed by Dunn's post-hoc test was employed. In the case of CPT as a damaging agent, cells were counted as adapted if the microcolony contained 3, 5 or more than 5 cell bodies. Four cell bodies were still considered arrested since a fraction of cells did not arrest with only 2 but 4 cell bodies at 4
h. This is due to a CPT-induced arrest in the next cell cycle if cells had already transitioned through S phase at the start of the experiment. Otherwise, quantification was performed in analogy to microcolony formation after X-ray.
Genomic DNA extraction
Exponentially growing cultures (20 mL of OD600nm 0. Subsequently, 500 µL isopropanol were added, the sample was mixed and centrifuged at 14,000 rpm for 15 min at 4 °C. After washing the pellet with 1 mL 70 % ethanol, DNA was air-dried at room temperature and resuspended gently in 50 µL 1x TE. Insoluble material was precipitated and removed following centrifugation at 14,000 rpm for 10 min at 4 °C.
DNA library preparation and sequencing
1 µg of genomic DNA was brought to a final volume of 50 µL and sheared using a Covaris S2 ultrasonicator system in a microTUBE AFA Fiber 6x16mm, applying the following shearing parameters: duty factor 10 %, intensity 5, 200 cycles per curst, 45 sec, 7 °C water bath temperature. After DNA shearing, a double-size selection was performed using Ampure XP beads with ratios of 0.6:1 (beads:DNA) to exclude larger fragments and 1:1 (beads:DNA) to remove smaller fragments. This procedure enriched the DNA for the 100-500 bp fragments. without collapsing adjacent windows (https://github.com/ENCODE-DCC/kentUtils) and normalized to reads per million (PRM). Using a custom made R script, RPM of each bin were then normalized to the sample-wide median RPM and chromosome copy numbers were estimated for each sample based on the chromosome median of this bin-wise RPM ratio (log2).
A cut-off of 0.6 or -0.6 was chosen to determine a higher or lower chromosome copy number than the other chromosomes in the same sample.
Pulsed-field gel electrophoresis
Exponentially growing cultures corresponding to 25 OD600nm units were collected by centrifugation at 5,000 rpm for 5 min and subsequently washed in 20 mL of 10 mM Tris-HCl, 50 mM EDTA, pH 7.5. Cells were resuspended in 500 µL spheroblasting buffer (0.056 M sodium phosphate, 0.2 M EDTA, 40 mM DTT) and preheated to 42 °C on a heat block. 2 % (w/v) low-melting point agarose in H2O was boiled and kept at 42 °C, and 500 µL (1:1) were mixed with the cells in spheroblasting buffer. 90-100 µL of the mix were pipetted into each plug mold (gives 10-12 plugs per sample). Once solidified at 4 °C, the plugs of each strain were transferred to large Falcons (50 mL) containing 3 mL of spheroblasting buffer supplemented with 0.08 mg/mL zymolyase. Plugs were incubated for 24 h at 37 °C, shaking. The plugs were washed with 10 mL 1 x TE buffer. Subsequently, 2 mL of Proteinase K buffer (10 mM TrisHCl, 0.42 M EDTA, 1 % N-lauroyl sarcosine, 2 mg/mL Proteinase K) were added and the plugs were incubated for a further 24 h at 50 °C, shaking. The plugs were washed five times with 10 mL of 10 mM Tris-HCl, 50 mM EDTA, pH 7.5. Plugs were stored in the same buffer at 4 °C until analysis. For the analysis, plugs were loaded on a 1 % agarose gel and sealed with 1 % agarose. Molecular weight marker CHEF DNA Size Marker #1703605 (Bio-Rad) was used.
The gel was run in a CHEF-DR® III system using the following settings: initial switch time 60
sec, final switch time 120 sec, run time 24 h, 6 volts/cm, included angle 120°. The gel was stained with ethidium bromide (1.25 µg/mL in TBE) for 30 min and destained for 10 min before imaging on a ChemiDoc™ Touch imaging system (Bio-Rad).
Hsp104-GFP microscopy
Overnight cultures were grown in YPD media at 25 °C. Cultures were diluted to 0.2 OD600nm units in 5 mL YPD media, and were grown for 3 h at 25 °C and afterwards shifted to 37 °C.
One mL of liquid culture was collected per time point by centrifugation at 3,000 rpm for 3 min. Imaging was performed using High-Content Screening Opera Phenix TM microscope (PerkinElmer) in confocal mode, using a water objective with 63x magnification. Fifteen independent fields with five planes each were imaged for each sample. Acquired images were analysed with Harmony High-Content Imaging and Analysis Software (version 4.4, PerkinElmer) using standard building blocks. First, nuclei were identified with algorithm M based on the DAPI signal. Second, cytoplasm was identified with algorithm A based on GFP signal. Cellular morphology properties were calculated with standard built-in algorithm, and cell roundness was set to 65 %. Spot detection of GFP foci was performed in the cytoplasm region of the cell with algorithm C. Cells on the periphery of images were excluded from analysis. We analysed data on the single cell level, with at least 3,000 cells per sample. The percentage of cell population that had Hsp104-GFP foci was calculated using Microsoft Excel 2013, and the data were visualized with the Prism 7.02 software package (GraphPad).
Representative images were processed using ImageJ 1.52g software. Of note, the cell number plated on X-ray treated plates was ten-times higher than the cell number plated on control plates or to assess cell survival in response to CPT. 
Growth curve assay and statistical analysis
